Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
fluticasone propionate and salmeterol
DRUG
2 trials
Sponsors
National Jewish Health
, Sanofi
Conditions
Asthma
Phase 2
Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
Completed
NCT02573233
Sanofi
Asthma
Start: 2016-01-27
End: 2018-01-03
Updated: 2022-04-04
Unknown Phase
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Completed
NCT01117116
National Jewish Health
Asthma
Start: 2010-03-01
End: 2013-09-01
Updated: 2026-07-06
Related Papers
Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma
Allergy
2026-05-29
Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial.
2024-07-01
2 citations
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR.
2023-09-04
35 citations
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines.
2021-12-08
14 citations
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
Respiratory Research
2020-10-13
37 citations